
It is of great significance to integrate genetic counseling and germline testing into the routine management of prostate cancer, especially for patients with high-risk disease, metastatic cancer, or a strong family history. Attention should be paid to timely referral for genetic counseling according to current clinical guidelines rather than relying solely on traditional clinicopathological factors. Although most genetic test results are negative or of uncertain significance, identifying pathogenic variants can provide valuable information for treatment selection, prognosis, and familial risk assessment, thereby supporting precision medicine in prostate cancer.
The cover image was produced with AI-generated content via ChatGPT, and the authors verify that it contains no copyrighted elements or misleading representation.
View this paper